Home > Boards > US OTC > Medical - Healthcare > Todos Med Ltd (TOMDF)

Agree; I'm glad I'm no longer invested financially

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Mister Silver Member Profile
 
Followed By 3
Posts 92
Boards Moderated 0
Alias Born 06/14/21
160x600 placeholder
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/18/2022 4:04:29 PM
Todos Medical signs 90-day agreement extension with convertible note holders Seeking Alpha - 12/13/2021 9:04:05 AM
SA Breaking News - PURA expects to sign first contracts this month InvestorsHub NewsWire - 12/2/2021 10:39:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/29/2021 4:02:25 PM
Todos Medical to acquire all 3CL protease biology-related assets and intellectual property from NLC Pharma Seeking Alpha - 11/29/2021 10:09:41 AM
Todos Medical inks licensing deal with T-Cell Protect forTtollovid products in Europe Seeking Alpha - 11/24/2021 2:58:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2021 6:09:53 AM
Todos Medical reports Q3 results Seeking Alpha - 11/16/2021 5:25:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2021 3:06:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 6:06:16 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/24/2021 9:59:38 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2021 9:25:51 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/24/2021 6:00:59 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/15/2021 4:18:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/27/2021 4:33:24 PM
Todos Medical inks distribution agreement with Fosun Pharma for COVID-19 test kit Seeking Alpha - 7/19/2021 9:02:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2021 4:02:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/8/2021 10:43:45 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/7/2021 4:02:57 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/6/2021 4:02:51 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/30/2021 4:03:26 PM
Todos Medical Ltd. reports Q1 results Seeking Alpha - 6/29/2021 11:24:03 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/29/2021 9:22:52 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/17/2021 4:18:12 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 5/13/2021 6:02:41 AM
Mister Silver   Wednesday, 06/30/21 08:29:14 AM
Re: leslunier post# 2998
Post # of 6359 
Agree; I'm glad I'm no longer invested financially with this company.

I really enjoy reading their updates though; I find them entertaining psychologically.

They no longer state what they are doing, they state what they 'believe', and 'expect'.

"We believe..."
"We expect..."

-----------------------------------------


The phrase "We believe" occurs 13 times in the document. Here are some examples. I've emboldened them, and also emboldened other terms within the same example that point to doubt.


- "We believe this government recognition of the need for antivirals will provide a significant tailwind for the development of our Tollovir™ antiviral"

- "We believe neutralizing antibody testing will become more critical to help determine robust COVID-19 immunity.”

- "we believe that we can compete for large volume COVID-19 testing business, and we expect to see a resurgence in this testing"

- "We believe that the significant strides we have made at Provista will position the Company to accelerate growth"

- "we believe it is critical to rapidly expand our clinical development programs"

- "We believe this CRO relationship will allow for the rapid expansion of enrollment for Tollovir’s clinical data acquisition"

- "We believe that Tollovir may ultimately represent a new standard of care in the treatment and management of COVID-19 patients"

- "We believe this authorization underscores the emerging need in the marketplace for immune support supplements"

- "we believe that independent funding to support sales and marketing for a Tollovid-focused entity, potentially through crowdfunding, may be the best use of the existing Tollovid commercial material and the best financing path forward"

- "We believe Videssa could ultimately represent a new standard of care in certain areas for breast cancer screening

- "We believe that payers will require patients to undergo amyloid PET imaging prior to prescribing Aduhelm."

- "we believe LymPro could also help drive mid-term value for Todos as progress is made."

- "We believe TBIA could ultimately represent an entirely new blood testing platform"

---------------------------------------------------------

They stated "We Expect" 4 times in the document. Again also emboldened other words of doubt.

- "We expect to build a significant international distribution footprint"

Note: To "Build" is a word/phrase of doubt because it implies it has not been built.

- "we expect to see a resurgence in this testing"

Note: (Resurgence implies it's ceased surging)

- "in identifying international distribution partners for Tollovid, and we expect to begin to make announcements on this front in the third quarter of 2021."

- "we expect Todos core TBIA artificial intelligence testing platform that currently has a CE Mark for Breast Cancer and Colon Cancer to be able to replace Videssa and LymPro"

------------------------------------------------------------

Bonus: "We are also optimistic about the interest we have seen from several potential international distribution partners for our dietary supplement Tollovid"

"We're optimistic" means "Nothing has been agreed to"



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences